Breaks Categories: News

MondaySep 25, 2017 9:32 am

NetworkNewsBreaks – The Green Organic Dutchman (“TGOD”) Introduces New CFO and VP of Horticulture

The Green Organic Dutchman Holdings Ltd. (“TGOD”) recently announced the hiring of Amy Stephenson as its new chief financial officer and David Peron as its new vice president of horticulture. Stephenson has over 20 years of executive experience in both the private and public sectors which includes working with market leaders in the Canadian cannabis industry. Peron is an agrologist and holds a master of science degree in plant sciences from McGill University. He is also chief science officer for Destiny Biotechnology, which provides living soil systems for organic cannabis production. “This is another step forward for The Green Organic…

Continue Reading

MondaySep 25, 2017 9:06 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on Advancements of Proprietary Biosynthesis Technology

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning provided an update to its investors on the significant advancements in the development of its proprietary technology for the microbial biosynthesis of cannabinoids. InMed has successfully demonstrated that it can selectively produce all four “gateway” cannabinoids using genetically engineered microorganisms. These molecules can be further functionalized to produce any of the 90+ cannabinoids that occur naturally in the cannabis plant. “Successful scale-up and commercialization of the biosynthesis process for cannabinoid production is a top priority for InMed,” Eric A. Adams, president and CEO of InMed, stated in…

Continue Reading

FridaySep 22, 2017 9:22 am

NetworkNewsBreaks – Alltemp (LTMP) Partners with Trinity to Offer Comprehensive Extended Warranty Coverage

Alltemp, Inc. (OTCQB: LTMP), a developer of proprietary, environmentally friendly refrigerant technologies, is now able to offer a strong third-party extended warranty for clients whose HVAC systems are running alltemp refrigerants backed by Trinity Warranty. The extended warranty plan is available to most alltemp users and can enhance the manufacturer’s warranty, with an option for up to a 10-year extension that can include parts and labor. “We believe that we designed alltemp to be the best refrigerant on the market and we are now backing it up with the best extended service agreements available,” William Lopshire, Alltemp CEO, said in…

Continue Reading

FridaySep 22, 2017 9:20 am

NetworkNewsBreaks – American Cannabis Company, Inc. (AMMJ) Signs Exclusive Distribution Agreement with Earth Alive

American Cannabis Company, Inc. (OTCQB: AMMJ), a full-service, business-to-business consulting solutions provider and seller of ancillary products to the cannabis industry, has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial technology-based products. This agreement allows Earth Alive’s premiere cannabis microbial inoculant product, “Dr. Marijane,” a certified organic root probiotic proven to increase cannabis yields by up to 28%, to be commercialized. “We are very happy to be given the opportunity to exclusively distribute Dr. Marijane,” Terry Buffalo, CEO of American Cannabis Company, Inc., said in a news release. “Dr.…

Continue Reading

ThursdaySep 21, 2017 1:59 pm

NetworkNewsBreaks – GB Sciences, Inc. (GBLX) Forges Innovative Partnership with LSU AgCenter to Advance Understanding of Cannabis

GB Sciences, Inc. (OTCQB: GBLX) and Louisiana State University ("LSU") AgCenter recently announced an agreement with GB Sciences Louisiana, LLC, a wholly owned subsidiary of GB Sciences, Inc., to produce medical cannabis products for qualifying patients. The agreement, conducted under compliance with the Alison Neustrom Act, will allow GB Sciences to produce medical cannabis under the AgCenter’s license. In a news release, GB Sciences, Inc. stated that the agreement is “historic” and creates a formidable partnership. GB Sciences is a publicly traded cannabis company firmly rooted in science. This partnership with LSU, a major research university, is dedicated to advancing…

Continue Reading

ThursdaySep 21, 2017 11:52 am

NetworkNewsBreaks – Tantech Holdings Ltd.’s (NASDAQ: TANH) Subsidiary Secures $20M Electric Vehicle Order

Tantech Holdings (NASDAQ: TANH) this morning said that its 70% owned subsidiary, Suzhou E Motors Buses Co., Ltd., has signed sales contracts for its electric vans and buses worth approximately $20 million. Per the contracts, Zhenjiang Baichuan New Energy Automobile Co., Ltd. intends to purchase 450 all-electric vans and 10 all-electric buses from Tantech with a projected unit sales price of U.S. $43,077. In addition to the unit sales price, Tantech may be eligible to receive Chinese government subsidies for electric car sales. Tantech is expecting to deliver the order by the end of 2017. "In addition to manufacturing a…

Continue Reading

ThursdaySep 21, 2017 11:50 am

NetworkNewsBreaks – Onconova Therapeutics, Inc. (NASDAQ: ONTX) Enters Strategic Collaboration with Cellectar Biosciences, Inc. (NASDAQ: CLRB) to Develop New PDCs

Shares of Onconova Therapeutics (NASDAQ: ONTX) are up 6% after the company this morning said it has entered into a strategic collaboration with Cellectar Biosciences (NASDAQ: CLRB) to develop new phospholipid drug conjugates (PDCs). The companies intend to combine Cellectar’s patented phospholipid ether delivery platform with select proprietary compounds or payloads from Onconova’s early stage product pipeline. Per the terms of the collaboration, Onconova will provide several compounds to Cellectar, which will then link to its PDC platform to create new, more precisely targeted antitumor agents. “We are focused on optimizing the delivery of our therapeutic compounds in the battle…

Continue Reading

ThursdaySep 21, 2017 11:45 am

NetworkNewsBreaks – 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) Acquires Three New Lithium Properties in Quebec

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) today announced the acquisition of three highly prospective hard-rock lithium properties in the James Bay region of Quebec, Canada. The properties, consisting of a combined 115 mineral claims on approximately 14,710 acres, complement the company’s asset portfolio of lithium-bearing spodumene-bearing pegmatite resources. “As we continue to aggressively advance our flagship Hidden Lake Lithium Project in NWT (Northwest Territories), we feel it is critical to maintain a pipeline of additional high-quality, early-staged, lithium pegmatite projects, each with potential as stand-alone opportunities,” Adrian Lamoureux, CEO of 92 Resources, said in a news release.…

Continue Reading

ThursdaySep 21, 2017 9:19 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Inclusion in CSE25 Index

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has been included in the CSE25 Index after qualifying as one of the 25 largest companies in the CSE Composite Index. Per the update, the CSE25 Index is a subgroup of the CSE Composite Index, which was launched in 2015 and currently includes nearly half of the exchange’s listed companies and over 75 percent of the trading activity on the Canadian Securities Exchange. The CSE25 Index includes the top 25 securities contained within the CSE Composite Index based on market capitalization. According to the…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) Strengthens IP Portfolio with Two New Method Patents Covering Technology

Shares of HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) are up 13% after the company this morning said it has been issued two new U.S. patents by the United States Patent and Trademark Office covering the company’s technology and applications of its technology. The first patent, entitled Molecular Malignancy in Melanocytic Lesions (U.S. Patent 9,758,829), was issued to HTG and the John Wayne Cancer Institute, who co-invented the technology. The patent claims a method of treatment on an indeterminate or atypical nevi that involves measuring the nucleic acid expression of certain biomarkers, including MAGEA2, PRAME, PDIA4, NR4A1, PDLIM7, B4GALT1, SAT1, RUNX1,…

Continue Reading